Steve Schonfeld’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.12M Buy
+93,567
New +$7.07M 0.02% 616
2025
Q2
– Sell
-7,552
Closed -$375K – 2270
2025
Q1
$375K Buy
7,552
+2,652
+54% +$147K ﹤0.01% 1703
2024
Q4
$311K Sell
4,900
-381
-7% -$22K ﹤0.01% 1597
2024
Q3
$260K Sell
5,281
-1,643
-24% -$77.1K ﹤0.01% 1719
2024
Q2
$312K Sell
6,924
-41,655
-86% -$1.42M ﹤0.01% 1672
2024
Q1
$3.02M Buy
48,579
+26,233
+117% +$1.7M 0.02% 838
2023
Q4
$1.29M Buy
22,346
+9,646
+76% +$494K 0.01% 947
2023
Q3
$597K Buy
12,700
+5,500
+76% +$275K ﹤0.01% 1162
2023
Q2
$320K Buy
+7,200
New +$255K ﹤0.01% 1377

Other funds holding IRON

Steve Schonfeld's IRON Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Disc Medicine (IRON) in Q3 2026: 93,567 shares worth $6.12M. The stake represents 0.02% of the portfolio and ranks #616 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in IRON as recently as Q1 2025.

Steve Schonfeld first reported a position in IRON in Q2 2023 and has held it in 9 quarters since. 236 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

  • Steve Schonfeld held 93,567 shares of Disc Medicine worth $6.12M as of Q3 2026.
  • Disc Medicine was a new Steve Schonfeld position in Q3 2026.
  • Disc Medicine made up 0.02% of Steve Schonfeld's portfolio in Q3 2026, its #616 holding.
  • Steve Schonfeld first reported a position in Disc Medicine in Q2 2023 and has held it in 9 quarters since.
  • 236 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.